CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice

BACKGROUND: Experimental and clinical trials have demonstrated the efficiency of bone marrow-derived mesenchymal stromal/stem cells (bMSCs) in the treatment of myocardial infarction. However, after intravenous injection, the ineffective migration of engrafted bMSCs to the hearts remains an obstacle,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Dong-Mei, Li, Yuan-Long, Li, Jie, Li, Qinglang, Lu, Guihua, Zhai, Yuansheng, Zhang, Juhong, Huang, Zhibin, Gao, Xiuren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865070/
https://www.ncbi.nlm.nih.gov/pubmed/31747966
http://dx.doi.org/10.1186/s13287-019-1439-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865070/
https://www.ncbi.nlm.nih.gov/pubmed/31747966
http://dx.doi.org/10.1186/s13287-019-1439-y

Ejemplares similares